These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 17885556)

  • 41. Sympathetic and cardiac baroreflex function in panic disorder.
    Lambert EA; Thompson J; Schlaich M; Laude D; Elghozi JL; Esler MD; Lambert GW
    J Hypertens; 2002 Dec; 20(12):2445-51. PubMed ID: 12473870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure.
    Kingwell BA; Thompson JM; Kaye DM; McPherson GA; Jennings GL; Esler MD
    Circulation; 1994 Jul; 90(1):234-40. PubMed ID: 8026003
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Noradrenaline reuptake and plasma dihydroxyphenylglycol during sustained changes in sympathetic activity in rabbits.
    Eisenhofer G; Cox HS; Esler MD
    J Auton Nerv Syst; 1991 Mar; 32(3):217-31. PubMed ID: 2037769
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans.
    Wallin BG; Esler M; Dorward P; Eisenhofer G; Ferrier C; Westerman R; Jennings G
    J Physiol; 1992; 453():45-58. PubMed ID: 1464839
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autonomic and respiratory characteristics of posttraumatic stress disorder and panic disorder.
    Blechert J; Michael T; Grossman P; Lajtman M; Wilhelm FH
    Psychosom Med; 2007 Dec; 69(9):935-43. PubMed ID: 17991823
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical significance of adrenoreactivity in patients with some paroxysmal disorders (panic attacks and migraine)].
    Akarachkova ES; Tabeeva GR; Volkova ZI; Dlusskaia IG; Striuk RI; Veĭn AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(1):43-5. PubMed ID: 12616738
    [No Abstract]   [Full Text] [Related]  

  • 47. Aging effects on human sympathetic neuronal function.
    Esler MD; Turner AG; Kaye DM; Thompson JM; Kingwell BA; Morris M; Lambert GW; Jennings GL; Cox HS; Seals DR
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R278-85. PubMed ID: 7840332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine.
    Eisenhofer G; Esler MD; Meredith IT; Dart A; Cannon RO; Quyyumi AA; Lambert G; Chin J; Jennings GL; Goldstein DS
    Circulation; 1992 May; 85(5):1775-85. PubMed ID: 1572033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parallel increases in noradrenaline reuptake and release into plasma during activation of the sympathetic nervous system in rabbits.
    Eisenhofer G; Cox HS; Esler MD
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep; 342(3):328-35. PubMed ID: 2280799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-unit analysis of sympathetic nervous discharges in patients with panic disorder.
    Lambert E; Hotchkin E; Alvarenga M; Pier C; Richards J; Barton D; Dawood T; Esler M; Lambert G
    J Physiol; 2006 Feb; 570(Pt 3):637-43. PubMed ID: 16308348
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Selective serotonin reuptake inhibitor attenuates the hyperresponsiveness of TLR2
    Sales MC; Kasahara TM; Sacramento PM; Rossi ÁD; Cafasso MOSD; Oyamada HAA; Hygino J; Alvim F; Andrade RM; Cristina Vasconcelos C; Bento CAM
    Immunology; 2021 Mar; 162(3):290-305. PubMed ID: 33112414
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder.
    Herrera-Guzmán I; Herrera-Abarca JE; Gudayol-Ferré E; Herrera-Guzmán D; Gómez-Carbajal L; Peña-Olvira M; Villuendas-González E; Joan GO
    Psychiatry Res; 2010 May; 177(3):323-9. PubMed ID: 20385412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma noradrenaline as an index of sympathetic tone in coronary arterial disease: the confounding influence of clearance of noradrenaline.
    McCance AJ; Forfar JC
    Int J Cardiol; 1990 Mar; 26(3):335-42. PubMed ID: 1968893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased cardiac sympathetic drive in renovascular hypertension.
    Petersson MJ; Rundqvist B; Johansson M; Eisenhofer G; Lambert G; Herlitz H; Jensen G; Friberg P
    J Hypertens; 2002 Jun; 20(6):1181-7. PubMed ID: 12023689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human sympathetic nerve biology: parallel influences of stress and epigenetics in essential hypertension and panic disorder.
    Esler M; Eikelis N; Schlaich M; Lambert G; Alvarenga M; Kaye D; El-Osta A; Guo L; Barton D; Pier C; Brenchley C; Dawood T; Jennings G; Lambert E
    Ann N Y Acad Sci; 2008 Dec; 1148():338-48. PubMed ID: 19120127
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of selective serotonin reuptake inhibitor on prefrontal-striatal connectivity is dependent on the level of TNF-α in patients with major depressive disorder.
    Liu K; Zhao X; Lu X; Zhu X; Chen H; Wang M; Yan W; Jing L; Deng Y; Yu L; Wu H; Wen G; Sun X; Lv Z
    Psychol Med; 2019 Nov; 49(15):2608-2616. PubMed ID: 30520409
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence.
    Meyer JH; Wilson AA; Sagrati S; Miler L; Rusjan P; Bloomfield PM; Clark M; Sacher J; Voineskos AN; Houle S
    Arch Gen Psychiatry; 2009 Dec; 66(12):1304-12. PubMed ID: 19996035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diminished functional properties of T regulatory cells in major depressive disorder: The influence of selective serotonin reuptake inhibitor.
    Jahangard L; Behzad M
    J Neuroimmunol; 2020 Jul; 344():577250. PubMed ID: 32344162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.